AnaptysBio, Inc. (ANAB)
54.90
-0.35
(-0.63%)
USD |
NASDAQ |
Feb 12, 16:00
54.36
-0.54
(-0.98%)
Pre-Market: 09:28
AnaptysBio Cash from Investing (Quarterly) : 103.28M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -- |
| Nektar Therapeutics | -94.87M |
| Rigel Pharmaceuticals, Inc. | -33.18M |
| CorMedix, Inc. | -291.32M |
| Verastem, Inc. | -8.279M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.36M |
| Cash from Financing (Quarterly) | -10.39M |
| Free Cash Flow | -145.42M |
| Free Cash Flow Per Share (Quarterly) | -0.9431 |
| Free Cash Flow to Equity (Quarterly) | -27.36M |
| Free Cash Flow to Firm (Quarterly) | -4.853M |
| Free Cash Flow Yield | -8.91% |